Ocular Therapeutix (OCUL) Non-Current Debt: 2013-2025

Historic Non-Current Debt for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $70.6 million.

  • Ocular Therapeutix's Non-Current Debt rose 4.13% to $70.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.6 million, marking a year-over-year increase of 4.13%. This contributed to the annual value of $68.5 million for FY2024, which is 4.13% up from last year.
  • As of Q3 2025, Ocular Therapeutix's Non-Current Debt stood at $70.6 million, which was up 1.02% from $69.9 million recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Non-Current Debt ranged from a high of $70.6 million in Q3 2025 and a low of $14.9 million during Q1 2021.
  • In the last 3 years, Ocular Therapeutix's Non-Current Debt had a median value of $67.1 million in 2024 and averaged $59.9 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Non-Current Debt crashed by 35.15% in 2021, and later soared by 188.08% in 2024.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Non-Current Debt stood at $25.0 million in 2021, then grew by 1.03% to $25.3 million in 2022, then skyrocketed by 160.47% to $65.8 million in 2023, then rose by 4.13% to $68.5 million in 2024, then climbed by 4.13% to $70.6 million in 2025.
  • Its Non-Current Debt was $70.6 million in Q3 2025, compared to $69.9 million in Q2 2025 and $69.2 million in Q1 2025.